Toll-like receptors in human skin
- Authors: Ionescu MA1
-
Affiliations:
- Issue: Vol 10, No 2 (2013)
- Pages: 50-55
- Section: Articles
- Submitted: 10.03.2020
- Published: 15.12.2013
- URL: https://rusalljournal.ru/raj/article/view/630
- DOI: https://doi.org/10.36691/RJA630
- ID: 630
Cite item
Abstract
Uriage patented complex TlR2-Regul® modulates the activity of toll-like receptors, which are the part of innate immune system. TlR2-Regul ®-containing emulsions used as monotherapy in patients with light seborrheic dermatitis, acne and atopic dermatitis significantly reduces the signs of skin inflammation.
Full Text
References
- Kang S.S.W. et al. J. Am. Acad. Dermatol. 2006, v. 54 (6), p. 951-83.
- Musette P. et al. Medecine. Science. 2006, v. 22, p. 149-152.
- Meyer T. et al. Br. J. Dermatol. 2007, v. 157 (2), p. 1-7.
- Wanx X. et al. Моl. Med. Report. 2011, v. 4 (3), p. 541-546.
- Hansel A. et al. J. Allergy. Clin. Immunol. 2011, v. 127 (3), p.787-794.
- Schwandner R. et al. J. Biol. Chem. 1999, v. 274, p. 1740617409.
- Yang R.B. et al. J. Immunol. 1999, v. 163, p. 639-643.
- Nagy I. et al. J. Invest. Dermatol. 2005, v. 124, p. 931-938.
- Lin P.T. el al. J. Immunol. 2005, v. 174, p. 2467-2470.
- Kurokawal. et al. Exp. Dermatol. 2009, v. 18 (10), p. 821-832.
- BellewS. eta l. J. Drugs. Dermatol. 2011, v. 10 (6), p. 582-585.
- Leyden J.E. et al. Br. J. Dermatol. 1974, v. 90, p. 525-530.
- Giustizieri M.L. et al. J. Allergy Clin. Immunol. 2001, v. 107, p. 871-877.
- Cho S.H. et al. J. Invest Dermatol. 2001, v. 116, p. 658-663.
- Harder J. et al. Nature. 1997, v. 387, p. 861.
- O’Neill D.A. et al. J. Immunol. 1999, v. 163, p. 6718-6724.
- Ong P.Y et al. N. Engl. J. Med. 2002, v. 347, p. 1151-1160.
- Niebuhr M. et al. Exp. Dermatol. 2011, v. 20 (6), p. 468-472.
- Baroni A. et al. Arch. Dermatol. Res. 2006, v. 297 (7), p. 280-288.
- Ionescu M.A. et al. G. Ital. Dermatol. Venereol. 2011, v. 146, p. 185-189.
- Dreno B. et al. Ann. Dermatol. 2007, v. 134, p. 451-455.